Faster decision-making is helpful, but in acute care medicine, safer decisions must remain our primary focus​.

Discover how a new nanophotonic chip uses genetic markers and AI to detect diseases in minutes, potentially revolutionising ...

In the race of innovative drug R&D, whether for antibodies, peptides, or novel binding proteins, the efficiency of early-stage molecule discovery is always the key factor determining project success ...

It’s not just one big blob of AI talk anymore; things have really started to break down into different areas, which is ...